{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:12:43Z","timestamp":1778706763163,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015668","name":"Ontario Ministry of Research and Innovation","doi-asserted-by":"publisher","award":["ER 10-07-182"],"award-info":[{"award-number":["ER 10-07-182"]}],"id":[{"id":"10.13039\/501100015668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OCN 126573"],"award-info":[{"award-number":["OCN 126573"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-130331"],"award-info":[{"award-number":["MOP-130331"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.yexcr.2021.112473","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T17:23:32Z","timestamp":1610299412000},"page":"112473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immunophenotypic characterization and therapeutics effects of human bone marrow- and umbilical cord-derived mesenchymal stromal cells in an experimental model of sepsis"],"prefix":"10.1016","volume":"399","author":[{"given":"Amir K.","family":"Varkouhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Teixeira Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajera","family":"Amatullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James N.","family":"Tsoporis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin M.","family":"Ektesabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley H.J.","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.yexcr.2021.112473_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"8","key":"10.1016\/j.yexcr.2021.112473_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"8","key":"10.1016\/j.yexcr.2021.112473_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"9749","key":"10.1016\/j.yexcr.2021.112473_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(10)60446-1","article-title":"Critical care and the global burden of critical illness in adults","volume":"376","author":"Adhikari","year":"2010","journal-title":"Lancet"},{"issue":"6917","key":"10.1016\/j.yexcr.2021.112473_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.yexcr.2021.112473_bib6","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.4049\/jimmunol.1103430","article-title":"Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections","volume":"188","author":"Pizzolla","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2021.112473_bib7","doi-asserted-by":"crossref","first-page":"i1585","DOI":"10.1136\/bmj.i1585","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/jtd.2018.11.74","article-title":"Improving clinical outcomes in sepsis and multiple organ dysfunction through precision medicine","volume":"11","author":"Mehta","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12717\/DR.2017.21.1.001","article-title":"Usage of human mesenchymal stem cells in cell-based therapy: advantages and disadvantages","volume":"21","author":"Kim","year":"2017","journal-title":"Dev Reprod"},{"key":"10.1016\/j.yexcr.2021.112473_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-9-12","article-title":"Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC","volume":"9","author":"Hass","year":"2011","journal-title":"Cell Commun. Signal."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cryobiol.2015.07.003","article-title":"Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects","volume":"71","author":"Marquez-Curtis","year":"2015","journal-title":"Cryobiology"},{"issue":"10","key":"10.1016\/j.yexcr.2021.112473_bib12","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.yexcr.2021.112473_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.yexcr.2021.112473_bib14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.2008.168534","article-title":"Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis","volume":"58","author":"Gonzalez-Rey","year":"2009","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.yexcr.2021.112473_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.humimm.2009.12.005","article-title":"Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells","volume":"71","author":"Raicevic","year":"2010","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4110\/in.2017.17.2.89","article-title":"Mesenchymal stromal cells and toll-like receptor priming: a critical review","volume":"17","author":"Najar","year":"2017","journal-title":"Immune Netw"},{"issue":"4","key":"10.1016\/j.yexcr.2021.112473_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib19","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1038\/s41598-017-08311-4","article-title":"Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections","volume":"7","author":"Johnson","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/stem.1543","article-title":"The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143","volume":"32","author":"Zhao","year":"2014","journal-title":"Stem Cell."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/187152809788462635","article-title":"Treatment of inflammatory diseases with mesenchymal stem cells","volume":"8","author":"Newman","year":"2009","journal-title":"Inflamm. Allergy - Drug Targets"},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s40778-016-0044-6","article-title":"MSC therapeutics in chronic inflammation","volume":"2","author":"Sargent","year":"2016","journal-title":"Curr Stem Cell Rep"},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.yexcr.2017.07.014","article-title":"Bone marrow-derived mesenchymal stem cells propagate immunosuppressive\/anti-inflammatory macrophages in cell-to-cell contact-independent and -dependent manners under hypoxic culture","volume":"358","author":"Takizawa","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.yexcr.2021.112473_bib24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/hum.2016.063","article-title":"Advances in stem cell and cell-based gene therapy approaches for experimental acute lung injury: a review of preclinical studies","volume":"27","author":"Mei","year":"2016","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.yexcr.2021.112473_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/cr.2010.44","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair","volume":"20","author":"Shi","year":"2010","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.yexcr.2021.112473_bib26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/CCM.0b013e31824317f7","article-title":"Mesenchymal stromal cells: cautious optimism for their potential role in the treatment of acute lung injury","volume":"40","author":"Lalu","year":"2012","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.yexcr.2021.112473_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","article-title":"Mesenchymal stromal cells: new directions","volume":"10","author":"Keating","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2021.112473_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2046-4053-3-48","article-title":"Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol","volume":"3","author":"Lalu","year":"2014","journal-title":"Syst. Rev."},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147170","article-title":"Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review","volume":"11","author":"McIntyre","year":"2016","journal-title":"PloS One"},{"issue":"38","key":"10.1016\/j.yexcr.2021.112473_bib30","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1073\/pnas.0907996106","article-title":"Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung","volume":"106","author":"Lee","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.yexcr.2021.112473_bib31","doi-asserted-by":"crossref","first-page":"L1003","DOI":"10.1152\/ajplung.00180.2011","article-title":"Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes","volume":"302","author":"Krasnodembskaya","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol. Lett."},{"issue":"Suppl 6","key":"10.1016\/j.yexcr.2021.112473_bib33","article-title":"Human allogeneic bone marrow and adipose tissue derived mesenchymal stromal cells induce CD8+ cytotoxic T cell reactivity","volume":"3","author":"Roemeling-van Rhijn","year":"2013","journal-title":"J. Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12929","article-title":"The influence of macrophages on mesenchymal stromal cell therapy: passive or aggressive agents?","volume":"188","author":"Carty","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2021.112473_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cmi.12580","article-title":"Macrophages: sentinels and regulators of the immune system","volume":"18","author":"Franken","year":"2016","journal-title":"Cell Microbiol."},{"issue":"5","key":"10.1016\/j.yexcr.2021.112473_bib36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","article-title":"Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta","volume":"97","author":"Horwitz","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yexcr.2021.112473_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)","volume":"30","author":"Ko\u00e7","year":"2002","journal-title":"Bone Marrow Transplant."},{"issue":"13","key":"10.1016\/j.yexcr.2021.112473_bib38","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.yexcr.2021.112473_bib39","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2021.112473_bib40","first-page":"583984","article-title":"What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow derived mesenchymal stromal cells?","volume":"2015","author":"B\u00e1rcia","year":"2015","journal-title":"Stem Cell. Int."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v6.i2.195","article-title":"Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility","volume":"6","author":"Nagamura-Inoue","year":"2014","journal-title":"World J. Stem Cell."},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/ALN.0000000000003018","article-title":"Human umbilical cord mesenchymal stromal cells attenuate systemic sepsis in part by enhancing peritoneal macrophage bacterial killing via heme oxygenase-1 induction in rats","volume":"132","author":"Jerkic","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.yexcr.2021.112473_bib43","doi-asserted-by":"crossref","first-page":"39889","DOI":"10.1038\/srep39889","article-title":"Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112473_bib44","doi-asserted-by":"crossref","first-page":"6901286","DOI":"10.1155\/2016\/6901286","article-title":"Umbilical cord as prospective source for mesenchymal stem cell-based therapy","volume":"2016","author":"Arutyunyan","year":"2016","journal-title":"Stem Cell. Int."},{"issue":"4","key":"10.1016\/j.yexcr.2021.112473_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.yexcr.2021.112473_bib46","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1634\/stemcells.20-6-530","article-title":"Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality","volume":"20","author":"Sekiya","year":"2002","journal-title":"Stem Cell."},{"issue":"6","key":"10.1016\/j.yexcr.2021.112473_bib47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/stem.651","article-title":"Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils","volume":"29","author":"Cassatella","year":"2011","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2021.112473_bib48","doi-asserted-by":"crossref","first-page":"3798465","DOI":"10.1155\/2016\/3798465","article-title":"Maresin 1 mitigates inflammatory response and protects mice from sepsis","volume":"2016","author":"Li","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"11","key":"10.1016\/j.yexcr.2021.112473_bib49","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.4049\/jimmunol.174.11.6561","article-title":"Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells","volume":"174","author":"Raes","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.yexcr.2021.112473_bib50","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/IAI.01220-05","article-title":"Mechanisms of mortality in early and late sepsis","volume":"74","author":"Xiao","year":"2006","journal-title":"Infect. Immun."},{"issue":"38","key":"10.1016\/j.yexcr.2021.112473_bib51","doi-asserted-by":"crossref","first-page":"20030","DOI":"10.1074\/jbc.M116.731216","article-title":"NADPH oxidases are essential for macrophage differentiation","volume":"291","author":"Xu","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.yexcr.2021.112473_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145342","article-title":"Novel markers to delineate murine M1 and M2 macrophages","volume":"10","author":"Jablonski","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molmed.2004.12.007","article-title":"The \"cytokine profile\": a code for sepsis","volume":"11","author":"Ulloa","year":"2005","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.00011606","article-title":"Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats","volume":"30","author":"Tillie-Leblond","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.yexcr.2021.112473_bib55","doi-asserted-by":"crossref","first-page":"L724","DOI":"10.1152\/ajplung.00233.2010","article-title":"Keratinocyte growth factor enhances barrier function without altering claudin expression in primary alveolar epithelial cells","volume":"299","author":"LaFemina","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.yexcr.2021.112473_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1164\/rccm.200709-1400OC","article-title":"Insulin-like growth factor-1 improves survival in sepsis via enhanced hepatic bacterial clearance","volume":"178","author":"Ashare","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yexcr.2021.112473_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ebiom.2018.05.023","article-title":"Mesenchymal stromal cells directly promote inflammation by canonical NLRP3 and non-canonical caspase-11 inflammasomes","volume":"32","author":"Chen","year":"2018","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.yexcr.2021.112473_bib58","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4049\/jimmunol.1400923","article-title":"Recombinant thrombomodulin inhibits lipopolysaccharide-induced inflammatory response by blocking the functions of CD14","volume":"194","author":"Ma","year":"2015","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.yexcr.2021.112473_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10456-014-9414-9","article-title":"Endothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia","volume":"17","author":"Silva","year":"2014","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.yexcr.2021.112473_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01054.x","article-title":"TWEAK\/Fn14 pathway: an immunological switch for shaping tissue responses","volume":"244","author":"Burkly","year":"2011","journal-title":"Immunol. Rev."},{"issue":"24","key":"10.1016\/j.yexcr.2021.112473_bib61","doi-asserted-by":"crossref","first-page":"21546","DOI":"10.1074\/jbc.M110.203745","article-title":"TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8","volume":"286","author":"Ikner","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:42:40Z","timestamp":1778704960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0014482721000045"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112473","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunophenotypic characterization and therapeutics effects of human bone marrow- and umbilical cord-derived mesenchymal stromal cells in an experimental model of sepsis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112473"}}